nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.103	0.103	CcSEcCtD
Diatrizoate—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0568	0.0568	CcSEcCtD
Diatrizoate—Respiratory distress—Hydrochlorothiazide—nephrolithiasis	0.0438	0.0438	CcSEcCtD
Diatrizoate—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0364	0.0364	CcSEcCtD
Diatrizoate—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0355	0.0355	CcSEcCtD
Diatrizoate—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0344	0.0344	CcSEcCtD
Diatrizoate—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0336	0.0336	CcSEcCtD
Diatrizoate—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0321	0.0321	CcSEcCtD
Diatrizoate—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.027	0.027	CcSEcCtD
Diatrizoate—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0248	0.0248	CcSEcCtD
Diatrizoate—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0229	CcSEcCtD
Diatrizoate—Injury—Hydrochlorothiazide—nephrolithiasis	0.022	0.022	CcSEcCtD
Diatrizoate—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0195	CcSEcCtD
Diatrizoate—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0189	CcSEcCtD
Diatrizoate—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0182	0.0182	CcSEcCtD
Diatrizoate—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0163	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0154	CcSEcCtD
Diatrizoate—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0153	CcSEcCtD
Diatrizoate—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0153	CcSEcCtD
Diatrizoate—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0151	CcSEcCtD
Diatrizoate—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Diatrizoate—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Diatrizoate—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Diatrizoate—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Diatrizoate—Flushing—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Diatrizoate—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Diatrizoate—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Diatrizoate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Diatrizoate—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Diatrizoate—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Diatrizoate—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Diatrizoate—Agitation—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Diatrizoate—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Diatrizoate—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0109	CcSEcCtD
Diatrizoate—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Diatrizoate—Cough—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Diatrizoate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Diatrizoate—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Diatrizoate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00994	0.00994	CcSEcCtD
Diatrizoate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00994	0.00994	CcSEcCtD
Diatrizoate—Shock—Hydrochlorothiazide—nephrolithiasis	0.00978	0.00978	CcSEcCtD
Diatrizoate—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00973	0.00973	CcSEcCtD
Diatrizoate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0097	CcSEcCtD
Diatrizoate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00961	0.00961	CcSEcCtD
Diatrizoate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00928	0.00928	CcSEcCtD
Diatrizoate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00892	0.00892	CcSEcCtD
Diatrizoate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00886	0.00886	CcSEcCtD
Diatrizoate—Pain—Hydrochlorothiazide—nephrolithiasis	0.0085	0.0085	CcSEcCtD
Diatrizoate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00819	0.00819	CcSEcCtD
Diatrizoate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00789	0.00789	CcSEcCtD
Diatrizoate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00785	CcSEcCtD
Diatrizoate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00713	0.00713	CcSEcCtD
Diatrizoate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00703	0.00703	CcSEcCtD
Diatrizoate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0068	0.0068	CcSEcCtD
Diatrizoate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00657	0.00657	CcSEcCtD
Diatrizoate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00632	0.00632	CcSEcCtD
Diatrizoate—Rash—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00626	CcSEcCtD
Diatrizoate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00626	CcSEcCtD
Diatrizoate—Headache—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00622	CcSEcCtD
Diatrizoate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0059	0.0059	CcSEcCtD
